

A | Aryan Khan's debut directorial series The Ba***ds of Bollywood is making waves. It has claimed the number one position on an annual ranking of the most popular Indian series of 2025. Reacting to the same, Aryan said, "Seeing The Ba***ds of Bollywood as the most popular web series on IMDb feels exactly like what we wanted to do. Shake the room and own the conversation, to make something that defines an entire genre in the modern era, a pop cultural phenomenon. I wanted this show to be a celebration of the madness, the magic, the mischief, and the raw ambition that fuels this industry. No soft edges, no pretending- we told the story the way it deserved to be told, and audiences across the world showed up for it in a massive way. The memes, the fan edits, the arguments, the obsession — that’s a show becoming part of culture, not just a weekend watch. I am grateful to everyone who clicked play, stayed with it, and made it explode the way it has. The joy this has brought the audience is why I do what I do- bringing stories that are straight from the heart. And this is just the beginning. The Ba**ds of Bollywood follows the journey of Aasmaan Singh (Lakshya), an ambitious outsider navigating the ruthless maze of stardom, glitz, and power struggles in Bollywood. Blending sharp satire with gripping drama, the show boldly peels back the curtain on the lesser-known truths of the film industry. The show features surprising cameos by icons like Shah Rukh Khan, Aamir Khan, Salman Khan, Karan Johar, and more. The Ba***ds of Bollywood is co-created by Aryan Khan, Bilal Siddiqi and Manav Chauhan with Gauri Khan producing under the banner of Red Chillies Entertainment. The series features a stellar ensemble cast including Lakshya Lalwani, Bobby Deol, Mona Singh, Raghav Juyal, Anya Singh, Manoj Pahwa, Manish Chaudhari, Sahher Bambba, Gautami Kapoor, Rajat Bedi, and more. Also Read: Farah Khan Praises Aryan Khan, Reveals Shah Rukh Khan Is Training Suhana Khan in Action for King。 在发表于《Oncotarget》杂志的一项研究中,约翰斯·霍普金斯大学医学院神经外科和肿瘤学教授Gregory Riggins博士和他的团队使用两种不同的小鼠模型来确定抗寄生虫药物甲苯达唑可以减缓或阻止早期和晚期胰腺癌的生长和扩散。“我们认为甲苯咪唑可能在所有阶段都有作用,”Riggins说。“它对早期发现的胰腺癌特别有效。”Riggins和他的团队将甲苯咪唑注射到经过基因工程改造后患上胰腺癌的小鼠身上。该团队测量了炎症和组织的变化,以及每个肿瘤的阶段、分级和转移状态。甲苯咪唑最初是通过切断寄生虫的营养供应来对抗蛔虫、钩虫和其他寄生虫感染,它能抑制微管蛋白的形成。Riggins解释说,微管蛋白既是细胞内部的微观“骨架”,也是“运输的高速公路”。该药物进入寄生虫的肠道并破坏微管蛋白,使寄生虫饿死。该研究表明,甲苯咪唑可能在胰腺癌中发挥类似的作用,通过塌陷癌细胞的结构,同时还有其他机制,如减少炎症。Riggins说,他希望通过人体临床试验继续他的团队的研究:“我们主张将甲苯咪唑作为一种疗法用于那些在转移前被诊断出来的人,看看我们是否可以减缓或预防胰腺癌,”Riggins说。“对于那些更晚期的癌症患者,它可能是某些手术的替代方案。甲苯咪唑作为初始治疗后的一种疗法可能有实用价值,以防止15%至20%接受手术的胰腺癌患者的肿瘤复发。

B | 它还可能增加其余80%至85%的晚期患者对标准化疗反应的持久性。
Current article:http://emlsa.zongchaeiwengshuabaisisuofu.sbs/list_1gsm/95cde.html
Published on:02:56:43
人民的名义_Random reading
年代秀_Active users
杀破狼_Hottest this week